179 related articles for article (PubMed ID: 25864037)
1. Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre study.
Tougeron D; Sickersen G; Mouillet G; Zaanan A; Trouilloud I; Coriat R; Aparicio T; Des Guetz G; Lecaille C; Artru P; Cauchin E; Sefrioui D; Boussaha T; Ferru A; Matysiak-Budnik T; Silvain C; Karayan-Tapon L; Pagès JC; Vernerey D; Bonnetain F; Michel P; Taïeb J; Lecomte T;
Eur J Cancer; 2015 May; 51(8):925-34. PubMed ID: 25864037
[TBL] [Abstract][Full Text] [Related]
2. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection.
Søreide K; Slewa A; Stokkeland PJ; van Diermen B; Janssen EA; Søreide JA; Baak JP; Kørner H
Cancer; 2009 Jan; 115(2):271-82. PubMed ID: 19109816
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.
Thomas ML; Hewett PJ; Ruszkiewicz AR; Moore JW
Asia Pac J Clin Oncol; 2015 Dec; 11(4):343-51. PubMed ID: 26471980
[TBL] [Abstract][Full Text] [Related]
6. Lymph node ratio is a stronger prognostic factor than microsatellite instability in colorectal cancer patients: results from a 7 years follow-up study.
Ferri M; Lorenzon L; Onelli MR; La Torre M; Mercantini P; Virgilio E; Balducci G; Ruco L; Ziparo V; Pilozzi E
Int J Surg; 2013; 11(9):1016-21. PubMed ID: 23747976
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.
Lamberti C; Lundin S; Bogdanow M; Pagenstecher C; Friedrichs N; Büttner R; Sauerbruch T
Int J Colorectal Dis; 2007 Feb; 22(2):145-52. PubMed ID: 16724208
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence.
Banerjea A; Hands RE; Powar MP; Bustin SA; Dorudi S
Colorectal Dis; 2009 Jul; 11(6):601-8. PubMed ID: 18637931
[TBL] [Abstract][Full Text] [Related]
9. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
Kim CG; Ahn JB; Jung M; Beom SH; Kim C; Kim JH; Heo SJ; Park HS; Kim JH; Kim NK; Min BS; Kim H; Koom WS; Shin SJ
Br J Cancer; 2016 Jun; 115(1):25-33. PubMed ID: 27228287
[TBL] [Abstract][Full Text] [Related]
10. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.
Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X
Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804
[TBL] [Abstract][Full Text] [Related]
11. P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.
Elsaleh H; Powell B; McCaul K; Grieu F; Grant R; Joseph D; Iacopetta B
Clin Cancer Res; 2001 May; 7(5):1343-9. PubMed ID: 11350904
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of microsatellite instability in T1 colorectal cancer.
Kang J; Lee HW; Kim IK; Kim NK; Sohn SK; Lee KY
Yonsei Med J; 2015 Jan; 56(1):175-81. PubMed ID: 25510762
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between microsatellite instability and morphology in colorectal cancer].
Szentirmay Z; Gallai M; Serester O; Szoke J; Tóth E
Magy Onkol; 2010 Jun; 54(2):169-78. PubMed ID: 20576594
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.
Elsaleh H; Iacopetta B
Clin Colorectal Cancer; 2001 Aug; 1(2):104-9. PubMed ID: 12445368
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive relevance of microsatellite instability in colorectal cancer.
Storojeva I; Boulay JL; Heinimann K; Ballabeni P; Terracciano L; Laffer U; Mild G; Herrmann R; Rochlitz C
Oncol Rep; 2005 Jul; 14(1):241-9. PubMed ID: 15944796
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma.
Srdjan M; Jadranka A; Ivan D; Branimir Z; Daniela B; Petar S; Velimir M; Zoran K
Indian J Med Res; 2016 May; 143(Supplement):S104-S111. PubMed ID: 27748284
[TBL] [Abstract][Full Text] [Related]
18. Oncologic results after multivisceral resection of clinical T4 tumors.
Eveno C; Lefevre JH; Svrcek M; Bennis M; Chafai N; Tiret E; Parc Y
Surgery; 2014 Sep; 156(3):669-75. PubMed ID: 24953279
[TBL] [Abstract][Full Text] [Related]
19. Role of microsatellite instability in the management of colorectal cancers.
Buecher B; Cacheux W; Rouleau E; Dieumegard B; Mitry E; Lièvre A
Dig Liver Dis; 2013 Jun; 45(6):441-9. PubMed ID: 23195666
[TBL] [Abstract][Full Text] [Related]
20. Sporadic colorectal carcinomas with low-level microsatellite instability in Korea: do they form a distinct subgroup with distinguished clinicopathological features?
Kim YH; Min BH; Choi HK; Kim SJ; Kim KM; Kim JY; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC; Chun HK
J Surg Oncol; 2009 May; 99(6):351-5. PubMed ID: 19204939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
